This project aims to advance candidate neuroprotective and axon regenerative therapies into proof-of-concept for safety and efficacy in NF1-OPG animal models as an essential step towards treatment of NF1-OPG patients.
Investigators
Jeffrey Goldberg, MD, PhD
Stanford University
School of Medicine
Jeffrey Goldberg, MD, PhD
Stanford University
School of Medicine
Current Stage
Discovery
In Vivo Proof of Concept
IND Enabling
Clinical Trial Phase 1
Clinical Trial Phase 2
Clinical Trial Phase 3